Advanced Biologics (ABC) focus is to develop innovative and clinically relevant biologic solutions across a wide degree of medical specialties. Our company is fully dedicated to improving patients' lives and the health care provider's experience with our products. ABC’s award-winning OsteoAMP® allogeneic-derived growth factor has shown to provide a true alternative to rhBMP-2 with clinical results showcasing faster, safer and denser bone growth. Other technologies to follow have included ProteiOS growth factor and OsseoGEN cellular bone matrix. As of 2015, ABC established a spin-off, Biologica Technologies, to focus on the sales, marketing and clinical research for ABC's products. www.biologicatechnologies.com